Inari Medical, Inc.
NARI · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $493,632 | $383,471 | $276,984 | $139,670 |
| % Growth | 28.7% | 38.4% | 98.3% | – |
| Cost of Goods Sold | $59,068 | $44,506 | $24,757 | $13,106 |
| Gross Profit | $434,564 | $338,965 | $252,227 | $126,564 |
| % Margin | 88% | 88.4% | 91.1% | 90.6% |
| R&D Expenses | $87,533 | $74,221 | $51,018 | $18,399 |
| G&A Expenses | $349,463 | $291,886 | $190,021 | $89,413 |
| SG&A Expenses | $350,663 | $292,843 | $190,365 | $89,746 |
| Sales & Mktg Exp. | $1,200 | $957 | $344 | $333 |
| Other Operating Expenses | $0 | $356 | -$18 | -$662 |
| Operating Expenses | $448,596 | $367,064 | $241,383 | $108,145 |
| Operating Income | -$14,032 | -$28,099 | $6,672 | $18,419 |
| % Margin | -2.8% | -7.3% | 2.4% | 13.2% |
| Other Income/Exp. Net | $18,278 | $1,914 | -$159 | -$4,630 |
| Pre-Tax Income | $4,246 | -$26,185 | $10,685 | $13,789 |
| Tax Expense | $5,882 | $3,082 | $845 | $0 |
| Net Income | -$1,636 | -$29,267 | $9,840 | $13,789 |
| % Margin | -0.3% | -7.6% | 3.6% | 9.9% |
| EPS | -0.029 | -0.55 | 0.2 | 0.43 |
| % Growth | 94.8% | -375% | -53.5% | – |
| EPS Diluted | -0.029 | -0.55 | 0.18 | 0.27 |
| Weighted Avg Shares Out | 56,771 | 52,838 | 49,816 | 32,034 |
| Weighted Avg Shares Out Dil | 56,771 | 52,838 | 55,594 | 51,555 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15,613 | $1,852 | $154 | $484 |
| Interest Expense | $196 | $294 | $295 | $1,135 |
| Depreciation & Amortization | $10,735 | $7,637 | $4,530 | $1,485 |
| EBITDA | $15,187 | -$18,254 | $15,510 | $16,409 |
| % Margin | 3.1% | -4.8% | 5.6% | 11.7% |